Benjamin Hickey Net Worth & Insider Trades

Benjamin Hickey - EVP, Mirati Therapeutics, Inc

As of January 24, 2023

What is Benjamin Hickey's Net Worth?

The current estimated net worth of Mirati Therapeutics, Inc's EVP, Benjamin Hickey, is estimated to be about $3.03M . Benjamin Hickey owns about 47,223 units of Mirati Therapeutics, Inc common stock. In the last 3 years at Mirati Therapeutics, Inc, Benjamin Hickey has sold an estimated value of $1.5M worth.

What is Benjamin Hickey's Past Insider Trading?

Benjamin Hickey's largest purchase order was 2,369 units , worth over $270.85K on March 22, 2021. Benjamin Hickey's largest sale order was 2,078 units , worth over $449.52K on January 8, 2021. In total, Benjamin Hickey has made about 10 transactions over 3 years of their time at Mirati Therapeutics, Inc. Benjamin Hickey usually trades in January, with the busiest year in 2022, 2023 and 2021. The most recent transaction was a sale order of 1,566 units , worth over $66.37K on January 19, 2023.

Benjamin Hickey

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Benjamin Hickey's Salary in 2020?

As EVP of Mirati Therapeutics, Inc, Benjamin Hickey has a total base salary of $484,346 . Benjamin Hickey received compensation valued at about $5,798,359 in 2020 after becoming EVP. The vast majority of their compensation came in the form of option awards of $2,499,988 , other earnings, plans or compensations of $297,675 , other earnings, plans or compensations of $297,675 , and other compensation of $16,296 .

What is Benjamin Hickey's' Mailing Address?

  • Mailing address is C/o Mirati Therapeutics 9393 Towne Centre Drive Suite 200 San Diego CA 92121 CA

Mirati Therapeutics, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Charles M. Baum, M.D., Ph.D. 2020 $615,013 $6,092,158 $498,161 $498,161 $14,250 $11,747,582
Charles M. Baum, M.D., Ph.D. 2019 $597,100 $7,474,287 $410,506 $410,506 $2,500 $8,484,393
Charles M. Baum, M.D., Ph.D. 2018 $579,700 $3,851,079 $434,800 $434,800 $2,500 $4,868,079
James Christensen, Ph.D. 2020 $500,000 $2,379,745 $303,750 $303,750 $16,301 $6,988,546
James Christensen, Ph.D. 2019 $435,000 $2,637,984 $217,500 $217,500 $2,500 $3,292,984
James Christensen, Ph.D. 2018 $374,385 $2,571,375 $247,200 $247,200 $2,500 $3,195,460
Daniel Faga 2020 $494,231 $4,999,987 $303,750 $303,750 $362,373 $9,160,360
Benjamin Hickey 2020 $484,346 $2,499,988 $297,675 $297,675 $16,296 $5,798,359
Jamie A. Donadio 2020 $1,439 - - - $422,122 $423,561
Jamie A. Donadio 2019 $373,900 $2,637,984 $186,950 $186,950 $2,500 $3,201,334
Jamie A. Donadio 2018 $363,000 $1,040,832 $217,800 $217,800 $2,500 $1,624,132
Isan Chen, M.D. 2020 $198,676 - - - $485,281 $683,957
Isan Chen, M.D. 2019 $433,100 $2,637,984 $216,550 $216,550 $2,500 $3,290,134
Isan Chen, M.D. 2018 $420,500 $1,040,832 $252,300 $252,300 $2,500 $1,716,132
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1576263/000162828021007114/mirati2021proxy.htm

What are Mirati Therapeutics, Inc's Past Insider Trades?

Mirati Therapeutics, Inc's most recent insider trade came on January 20, 2023 by Julie Cherrington who sold 2,546 units worth $113.7K . In the last 10 years, insiders at Mirati Therapeutics, Inc have sold an estimated value of $615.79M and bought an estimated value of $132.69M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Jamie Christensen, EVP,  Charles Baum, PresidentFounder,Head R&D,  and Braslyn Ltd .

Mirati Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...